All Pharma News
FibroGen to Report First Quarter 2024 Financial Results

FibroGen to Report First Quarter 2024 Financial Results
GLOBENEWSWIRE
29 Apr 2024
Share Share
FibroGen`s FG-3246 + Enzalutamide Data at ASCO 2024

FibroGen`s FG-3246 + Enzalutamide Data at ASCO 2024
GLOBENEWSWIRE
24 Apr 2024
Share Share
FibroGen, former employees settle dispute over alleged trade secrets theft

FibroGen, former employees settle dispute over alleged trade secrets theft
FIERCE PHARMA
20 Apr 2024
Share Share
Prostate cancer ADC breaks FibroGen`s clinical losing streak

Prostate cancer ADC breaks FibroGen`s clinical losing streak
James Waldron FIERCE BIOTECH
03 Apr 2024
Share Share
FibroGen Announces Results from Ph 1 of FG-3246 for Prostate Cancer

FibroGen Announces Results from Ph 1 of FG-3246 for Prostate Cancer
GLOBENEWSWIRE
02 Apr 2024
Share Share
FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference

FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference
GLOBENEWSWIRE
26 Mar 2024
Share Share
FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
GLOBENEWSWIRE
11 Mar 2024
Share Share
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States

FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States
GLOBENEWSWIRE
26 Feb 2024
Share Share
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results

FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
26 Feb 2024
Share Share
FibroGen to Report Fourth Quarter and Full Year 2023 Financial Results

FibroGen to Report Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
20 Feb 2024
Share Share